Ricco caught by secret doping molecule
November 22, 2024
Login
Home
News
Ride Maps
Blogs
Forums
Gear
Resource
VeloTV
Photos
Current Articles
|
Archives
|
RSS Feeds
|
Search
Wednesday, July 23, 2008
Ricco caught by secret doping molecule
by Agence France-Presse at 7:13 AM EST
comments
Categories:
Pro Cycling
,
Doping
The world doping agency said Wednesday Italian rider Riccardo Ricco tested positive at the Tour de France after a secret molecule was planted in the blood booster EPO during its manufacture.
Ricco, 24, upset the big names of the sport to win two stages of this year's Tour before he was kicked off after testing positive for EPO (erythropoietin).
Revealing the now high-tech nature of the fight against drugs in sport, World Anti-Doping Agency chief John Fahey said his organisation worked with drugs giant Roche on the newest version of EPO (erythropoietin).
He said Roche had included a molecule in the third generation of EPO, called Continuous Erythropoiesis Receptor Activator (CARA), that acted as a flag in drug tests showing when an athlete was using the substance. "In the development of that particular substance, close cooperation occurred between WADA and the pharmaceutical company Roche Pharmaceuticals so that there was a molecule placed in the substance well in advance that was always going to be able to be detected once a test was taken," Fahey told public radio in his native country Australia.
Until this year's Tour, the CARA EPO, which is released into the body more slowly than its predecessors, had been thought to be virtually undetectable by drug testers.
Fahey said such cooperation with drug companies was the way forward in fighting drug cheats. "There's more and more of this occurring," he said. "The more cooperation the scientists can have with the drug companies in the detection of performance-enhancing drugs the greater the likelihood is they will be detected when tests are undertaken."
Ricco is one of three riders to test positive for EPO at this year's tour, tarring the race once again with a drugs controversy. He has denied using the substance, which was developed to boost oxygen levels in the blood of people with anemia who also have kidney disease. It has been banned in sports as it gives athletes an unfair advantage over their rivals.
comments
Follow @Pro_Cycling
Tweet
Subscribe via RSS or daily email
Contact the editor about this article
WHAT'S HAPPENING RIGHT NOW
RECENT
READ
Darach McQuaid acknowledges June deadline for plans to restart Tour of Ireland in 2015
Third climbing stage to feature on Presidential Tour of Turkey route, GC battle will be more intense
Philip Lavery interview: Walking away from the sport, then getting a second chance
Stetina wants rethink on dossards: ‘Cycling is still an amateur sport in so many ways’
Walker undergoes heart operation, retires; Philip Lavery to take his place on Synergy Baku team
McQuaid ends his part in legal action against Kimmage, Verbruggen persists
Planned new finale to Milan Sanremo in doubt after La Pompeiana climb and descent deemed too dangerous
Degenkolb beats Hushovd in bunch sprint to make it three from three in the Tour of the Mediterranean
Froome set to begin season in Tour of Oman, gunning for strong overall result
Past winner Gesink feeling on course for strong result in Tour of Oman
Wiggins admits pressure got to him in 2013, speaks about difficulty of being defending Tour champion
Démare swoops to victory on concluding stage of Tour of Qatar, Terpstra takes overall
Degenkolb notches up first win of his 2014 season on stage one of Tour of the Mediterranean
NetApp Endura still perfecting sprint train for Bennett
Greipel fastest in battle for Tour of Qatar’s fifth stage
No articles match criteria.
Terms and Conditions
|
Privacy Policy
Copyright 2008-2013 by VeloNation LLC
About
Advertising
Mission
Contact
Jobs
Content
Pro Cycling News
General Cycling Articles
Training and Health
Gear Reviews
Community
Directory
Blogs
Photos
Forums
Groups
VeloTV